. Undue reliance should not be placed on forward-looking
statements, especially guidance on future financial performance, which
speaks only as of the date they are made. BioForm Medical undertakes no
obligation to update publicly any forward-looking statements to reflect new
information, events or circumstances after the date they were made, or to
reflect the occurrence of unanticipated events.
Contact:
Adam Gridley
650.286.4025
Vice President, Corporate Development
BioForm Medical, Inc.
BIOFORM MEDICAL, INC.
SUMMARY OF OPERATIONS (unaudited)
(in thousands, except per share data)
Three months ended Twelve months ended
June 30, June 30,
2008 2007 2008 2007
Net U.S. sales $13,220 $12,726 $54,393 $39,215
Net International sales 3,492 2,624 13,090 8,199
Net sales 16,712 15,350 67,483 47,414
Cost of sales 2,289 2,901 11,393 8,769
Gross profit 14,423 12,449 56,090 38,645
Operating expenses:
Sales and marketing 17,702 11,783 56,912 38,186
Research and development 2,690 3,763 9,313 7,756
Acquired in-process research
and development 11,230 - 11,230 -
General and administrative 3,090 1,957 9,882 6,990
Total operating expenses 34,712 17,503 87,337 52,932
Other income (expense), net
Interest income, net 412 199 1,902 842
Other income (expense), net (51) 6 110 68
Lo
'/>"/>
SOURCE BioForm Medical, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related biology technology :1.
BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 20082.
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound3.
QMed, Inc. Reports July Medicare SNP Enrollments4.
Phlo Affiliate Reports Expanded Coverage to Oregon Border5.
Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results6.
Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 20077.
Carrington Reports Second Quarter 2007 Results8.
Avitar Reports Third Quarter Financial Results for Fiscal 20079.
Response Genetics Reports Second Quarter 2007 Financial Results10.
Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results11.
Transgenomic, Inc. Reports Second Quarter 2007 Results